The NIFTy Trial: NIRF Imaging to prevent PoSH after Thyroid Surgery - A phase II/III pragmatic, multicentre randomised controlled trial
ISRCTN: 59074092
🔊The NIFty trial is now OPEN! 🔊
NIFTy is investigating Near Infrared Fluorescence (NIRF) Imaging to prevent Post-surgical Hypoparathyroidism (PoSH) after Thyroid Surgery.
Coordinated by @leeds_stc
Here’s the recording of the @BAETS webinar on fluorescent imaging in thyroid cancer and @NiftyTrial in case you missed it.
https://t.co/FIUBamXIOu via @YouTube
It’s our 18th birthday today!! What a long way we’ve come since 2005 - and we’re not stopping yet. Big love and thanks to all our volunteers, members, advisors, partners and friends from all of us at Parathyroid UK. You’re all stars! 🌟
📢We have surpassed 1⃣5⃣0⃣ participants on the @NiftyTrial 👍 Well done to our fantastic sites especially Lister for recruiting no. 150 👏 Thank you to the sites for their continued support & of course, a great big thank you to the patients who agree to take part! #thyroidsurgery
📢May was a great month for recruitment! All our @NiftyTrial sites randomised participants & we hit our highest monthly recruitment figure with 2⃣2⃣ randomisations! Well done & thank you to our fantastic teams for continuing to support the trial! 👏🙏#hypopara#thyroidsurgery
Don't forget to register for the @BAETS webinar tomorrow 4th May at 8pm. This session is from the @NIFTy trial team about 'Fluorescent imaging in thyroid surgery – introduction and updates on the UK NIHR funded multi-centre NIFTy trial’.
https://t.co/CIqocxTLso @NiftyTrial
March was our highest recruiting month to date on the @NiftyTrial with 1⃣7⃣ randomisations - well done to the sites who recruited in March 👏 We are so close to 100 participants - can we reach this milestone in April & who will recruit number 100? #hypopara#surgicalresearch
🔊Shout out to our highest recruiting @NiftyTrial site Lister & Stevenage who have recruited 4⃣ patients already this month taking them over 3⃣0⃣ randomisations so far. Well done & thank you for your support of the trial! @GMochloulis@CarinaCruzRN#surgicalresearch#hypopara
📢We would like to wish the teams at our @NIFTyTrial sites a very Happy New Year📢Plus say a huge well done for another month of fantastic recruitment - In December all sites contributed to the recruitment total & we have surpassed the 5⃣0⃣ milestone! #surgerytrials#hypopara
📢Well done to all our @NIFTy sites for record recruitment in November. 1⃣6⃣ randomisations and double the previous month! It was also the first month that all 4 sites randomised participants! 👏 #thyroidsurgery#surgicalresearch#hypoparathyroidism
📢Our 2 newest sites on the @NiftyTrial have recruited their first patients! Well done @aimeedimarco & team at Hammersmith & the team at @ChelwestFT. What a fantastic start! 👏👏👏